Vineet Datta, Senior Director of Global Strategy at Datar Cancer Genetics Limited, shared a post on LinkedIn:
“It’s almost upon us again. Time to elevate the quality, clinical outcomes, and efficiency of cancer care delivery discussions at the American Society of Clinical Oncology (ASCO) Annual 2026 meeting in Chicago.
This meeting brings together a vibrant community of cancer professionals committed to improving patient care and fostering collaboration.
That includes Stefan Schuster and myself. Join us and our Datar Cancer Genetics Limited colleagues at the ASCO 2026 meeting.
DM us or reach us via the ASCO app link. See you in Chicago, where the team showcases 15 posters featuring innovative tech-science across the cancer ecosystem and discusses recent USFDA-cleared CellDx Tissue data and upcoming research plans for physician engagement.”
Other articles about ASCO on OncoDaily.